Producer Price Index (PPI) report is out and it offered extra insight into the state of the U.S. economy. The big news is that ...

A rift appeared to open Sunday between some of President Donald Trump’s agency heads and Elon Musk, the billionaire tasked with reforming the federal government, over Musk’s demand that all ...

City analysts believe the motor finance saga could cost the banking sector billions of pounds and compared it to the £50billion payment protection insurance (PPI) debacle a decade ago.

The group has set aside an extra £700million for potential compensation relating to motor finance, which has been dubbed 'PPI on wheels' by those fearing a rerun of the payment protection ...

STOCKHOLM, Feb. 20, 2025 /PRNewswire/ -- Sobi® and Apellis Pharmaceuticals today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli ...

has validated an indication extension application for Aspaveli ® (pegcetacoplan) for the treatment of C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis ...

WALTHAM, Mass. and STOCKHOLM, Sweden, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi ® (STO:SOBI) today announced the European Medicines Agency (EMA) has ...

Provides files to download data as it existed for this dataset on previous dates. Statistics are most often revised for 1 of 2 reasons: For certain statistics initial estimates are released with the ...

We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.

The approval of these two indications is based on results from the LITESPARK-004 and LITESPARK-005 trials, respectively. Also Read: Analysts Defend Merck Amid Investor Concerns Over Weak Guidance ...

the FDA may award a TDPRV for NP-300 for this indication, the expectation that, due to the sunset of the FDA's other two PRV program, there will possibly be fewer PRVs available for purchase ...

Rob Demovsky of ESPN.com reports that “strong indications” in Green Bay are that Alexander has played his final down for the team. Alexander’s unavailability is the biggest reason why the team is ...